PF-06741086 Multiple Dose Study in Severe Hemophilia

Clinical trial NCT02974855 · COMPLETED

Trial details

NCT number: NCT02974855
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hemophilia A or B

Start date: 2017-03-08
Primary completion: 2018-12-03
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.